Fonar Corporation (FONR) Stock

DelistedNasdaq: FONRFONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States.

19.09
Final close · Jun 2, 2026

FONR is no longer traded. Fonar was delisted from the Nasdaq in June 2026.

Prices on this page are historical; the last trade was June 2, 2026 at $19.09.

Fonar stock price history

Split-adjusted closes, 1987–2026

FONR final trading statistics

Final close
$19.09
Final trading day
Jun 2, 2026
Market cap at delisting
$117.76M
Shares outstanding
6.17M
Final 52-week range
$13.62 – $19.13
Avg. volume (final 3 mo.)
79,281
All-time high (split-adj.)
$112.50 · Mar 2000
All-time low (split-adj.)
$0.00 · Nov 1981
Return since IPO
+163062.4%
Beta
0.95
Book value / share
$27.01
Price / book
0.71
Final 52 wk
13.6219.13

Fonar earnings per share

Earnings per share

Fonar revenue & net income

RevenueNet income

Fonar annual financials

Fonar Corporation revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2025$104.35M$8.3M$0.93
FY2024$102.88M$10.6M$1.41
FY2023$98.65M$9.4M$1.30
FY2022$97.59M$12.4M$1.74
FY2021$89.93M$10.2M$2.64

Last five fiscal years reported before the delisting; fiscal year ending June. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Fonar Corporation

FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments: Medical Equipment, and Physician Management and Diagnostic Services. The company offers an Upright MRI scanner, which allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. It also provides non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with legal and regulatory matters, and development and implementation of practice growth and marketing strategies. In addition, the company owns and operates diagnostic imaging facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1978 and is based in Melville, New York.

Fonar stock FAQ

What happened to Fonar stock?

Fonar stock was delisted from the Nasdaq. Its final close was $19.09 on June 2, 2026.

Is FONR stock still trading?

No. FONR was delisted from the Nasdaq in June 2026 and no longer trades on a U.S. exchange.

What was the last price of FONR stock?

FONR closed at $19.09 on its final trading day, June 2, 2026, for a market value of about $117.76M.

What were Fonar's revenue and earnings in its last full fiscal year?

Fonar reported revenue of $104.35M and net income of $8.3M in fiscal 2025, its last full year as a public company.

When did Fonar go public?

Fonar Corporation stock began trading on January 1, 1987.

Diagnostics & Research stocks to research

All Healthcare stocks →